• Home
  • About Us
    • Meet Our Team
    • Vision, Mission and Core Values
    • Trusted Partners
    • Giving Back
    • In the News
    • Awards
    • Careers
  • For Patients
    • Study Opportunities
    • Clinical Trial Opportunities
    • Sign Up to Participate
    • Types of Research
    • Find Us in the Community
    • Frequently Asked Questions
    • Testimonials
    • How We Use Your Information
    • Newsletters
  • For Researchers
    • Patient/Caregiver Panels
    • Pricing
    • Proposal Requests
    • Frequently Asked Questions
    • Industry Conferences
    • Diseases
      • Hemophilia
      • Multiple Sclerosis
      • Breast Cancer
      • Diabetes
      • Multiple Myeloma
      • Epilepsy
      • Non-Small Cell Lung Cancer
      • HIV
  • Referral Program
  • Blog
    • Patient Blog
    • Business Blog
  • Sign In
  • Case Studies
    • The Long and Winding Road to Care
    • Health Literacy Initiative’s PSA
    • Patient Perspectives on Clinical Trial Participation
    • Patient Journeys and Insights for Oncology and Rare Diseases
    • Market Access: A Patient Perspective
    • The Impact of Rare Diseases on Patients and Caregivers
    • The Role of Patient Advocacy Groups
    • Zebras Do Exist: The Diagnostic Odyssey of Rare Disease Patients
    • Patient Insights on Telehealth: A Case Study
    • Hearing is Believing: Reducing Barriers to Amplify the Patient Voice

Rare Patient Voice

Helping Patients with Rare Diseases Voice Their Opinions

  • Home
  • About Us
    • Meet Our Team
    • Vision, Mission and Core Values
    • Trusted Partners
    • Giving Back
    • In the News
    • Awards
    • Careers
  • For Patients
    • Study Opportunities
    • Clinical Trial Opportunities
    • Sign Up to Participate
    • Types of Research
    • Find Us in the Community
    • Frequently Asked Questions
    • Testimonials
    • How We Use Your Information
    • Newsletters
  • For Researchers
    • Patient/Caregiver Panels
    • Pricing
    • Proposal Requests
    • Frequently Asked Questions
    • Industry Conferences
    • Diseases
      • Hemophilia
      • Multiple Sclerosis
      • Breast Cancer
      • Diabetes
      • Multiple Myeloma
      • Epilepsy
      • Non-Small Cell Lung Cancer
      • HIV
  • Referral Program
  • Blog
    • Patient Blog
    • Business Blog
  • Sign In
  • Case Studies
    • The Long and Winding Road to Care
    • Health Literacy Initiative’s PSA
    • Patient Perspectives on Clinical Trial Participation
    • Patient Journeys and Insights for Oncology and Rare Diseases
    • Market Access: A Patient Perspective
    • The Impact of Rare Diseases on Patients and Caregivers
    • The Role of Patient Advocacy Groups
    • Zebras Do Exist: The Diagnostic Odyssey of Rare Disease Patients
    • Patient Insights on Telehealth: A Case Study
    • Hearing is Believing: Reducing Barriers to Amplify the Patient Voice

Helping patients and caregivers share their voices

Patients Rate their Clinical Trial Experience Positively, but Trial Locations Still Pose Barriers to Enrollment

July 27, 2021 Laura Mullen

New Informa Pharma Intelligence/Rare Patient Voice survey uncovers patient sentiment on clinical trial participation

NEW YORK, July 27, 2021 (GLOBE NEWSWIRE) — Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, released its first “Patient Perspectives on Clinical Trial Participation” report, which measured patient attitudes in relation to all stages of the clinical trial process following the onset of the COVID-19 pandemic.

The study, conducted online in partnership with Rare Patient Voice LLC, the leading firm connecting patients and caregivers with opportunities to make their voices heard through surveys, interviews, and other studies, reveals how the appetite for engaging with these trials has changed in the past year and identifies what specific factors are driving and preventing initial participation.

“Patient feedback is crucial to improving the clinical trial process, not only so clinical trial sponsors can better the trials themselves, but also so they can eliminate enrollment barriers, maximize resources, and accelerate trial timelines,” said Mike Wenger, Vice President of Patient Engagement at Informa Pharma Intelligence. “Our study found that individuals are generally pleased with their clinical trial experience, but organizers could benefit from working more closely with physicians and being strategic about trial locations to boost enrollment and increase accessibility.”

“Considering the patient experience in the design of clinical trials is essential,” said Pam Cusick, Senior Vice President of Rare Patient Voice. “Improving the overall experience by encouraging physicians to share more regularly about clinical trials, making it easier for patients to participate, and providing updates and outcome data will ensure that more patients want to be part of clinical trials in the future.”

Physicians Play a Key Role in Enrollment

Even though personal physicians may not be directly involved in ongoing clinical trials, they do drive the majority of patient enrollment. According to the survey, nearly half (48%) of respondents who had participated in a clinical trial found out about the trial through their physician. Even 81% of respondents who had NOT participated in a clinical trial indicated they’d be more likely to participate if they were referred by their physician.

Conversely, only 23% of respondents who had participated in clinical trials used ClinicalTrials.gov when searching for trial information, indicating that direct referrals from medical personnel are nearly twice as likely to result in enrollment. While this platform can be a reliable source of information, it is clear that targeted recommendations from trusted physicians carry more weight when it comes to participation.

Location Creates Barriers to Participation

Moving forward, trial sponsors should prioritize location during the planning process to not only make the trial more accessible, but to also maximize enrollment potential and reduce the chance of investing in non-performing sites.

Nearly half (47%) of respondents who had not participated in a clinical trial said this was because they were unable to find a nearby trial location which related to their disease or condition, and 67% indicated they would be more likely to participate if they found a suitable study nearby.

Patient Experience is Positive, but Communication is Key

Overall, 84% of respondents who had participated in clinical trials described their experience positively, and 86% expressed satisfaction with weekly, bi-weekly, or monthly communication from trial sponsors. However, sponsors should take special care to maintain this level of communication, as 34% of participants receiving communication less often than once a month felt that was insufficient.

Additionally, over 60% of respondents had NOT received results of the study they participated in, and 64% believed this to be important. These findings reveal a clear demand for sponsors to continue communicating study developments to participants, even after their portion of the trial has concluded.

In addition to frequent communication, a speedy enrollment process also contributed to positive patient feedback. Highly rated trial experiences also have ripple effects: 87% of those who had participated in a clinical trial said they were likely to participate in another, and 84% said they would recommend participation to others. Respondents also expressed altruistic motivations for repeatedly enrolling in clinical trials, with 29% citing a desire to help others and 25% hoping to assist in the search for cures and more effective treatments.

For more information about the full study, visit Informa Pharma Intelligence.

Research Methodology
Total sample size was 935 respondents ages 15-84. Fieldwork was undertaken in May 2021. The survey was carried out online.

About Informa Pharma Intelligence
Informa Pharma Intelligence powers a full suite of analysis products – including Datamonitor Healthcare™, Sitetrove™, Trialtrove™, Pharmaprojects™, Biomedtracker™, Scrip™, Pink Sheet™ and In Vivo™ – to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth. With more than 400 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information, visit pharmaintelligence.informa.com.

About Rare Patient Voice
Rare Patient Voice, LLC provides patients and caregivers an opportunity to voice their opinions through surveys and interviews to improve medical products and services. RPV has over 100,000 patients across 618 different conditions. For more information, visit rarepatientvoice.com.

Filed Under: Business, Patient, Press Releases Tagged With: clinical trial participation, ClinicalTrials.gov, Informa, patient enrollment, patient feedback, Pharma Intelligence, physicians, Rare Patient Voice, survey

Latest Blog Posts

  • 10 RPV Facts for 10 Years
  • Weekly Warrior: Meet Angela
  • Weekly Warrior: Meet Emily
  • Weekly Warrior: Meet Dani
  • Meet Our Team: Jennifer Harscheid, Project Manager

Check Out Our YouTube Channel!

https://youtu.be/cfjkqh5Ykp0

Read Our Newsletter

Read our Newsletter
What’s New at Rare Patient Voice?

Rare Patient Voice

711 Hampton Lane
Towson, Maryland 21286
ContactUs@RarePatientVoice.com
(443) 986-1949


Visit our international site, rarepatientvoice.global


Careers


For Patients

  • Learn about us
  • Vision, Mission and Core Values
  • Sign up to participate
  • Find us in the community
  • Read our blog for patients
  • Privacy Policy

For Related Groups

  • What is the Rare Patient Voice referral program?
  • Are you a researcher?
  • Read our blog for businesses

   Instagram TikTok

     
     

Rare Patient Voice, LLC, Market Research, Towson, MD

Rare Patient Voice, LLC, Market Research, Towson, MD

©2023. Rare Patient Voice. All Rights
Reserved. Privacy Policy. Disclaimers. Sitemap

©2023 . All Rights Reserved.

Copyright © 2023 · Genesis Framework · WordPress · Log in

Search Our Website

We use cookies to ensure the best experience with Rare Patient Voice. By clicking “Accept”, you agree to our privacy policy.
Privacy Policy   |    Cookies    |    Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT